A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
Abstract
Share and Cite
Liu, Y.; Jiang, Z.; Zhou, X.; Li, Y.; Liu, P.; Chen, Y.; Tan, J.; Cai, C.; Han, Y.; Zeng, S.; et al. A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma. J. Clin. Med. 2023, 12, 1286. https://doi.org/10.3390/jcm12041286
Liu Y, Jiang Z, Zhou X, Li Y, Liu P, Chen Y, Tan J, Cai C, Han Y, Zeng S, et al. A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma. Journal of Clinical Medicine. 2023; 12(4):1286. https://doi.org/10.3390/jcm12041286
Chicago/Turabian StyleLiu, Yongting, Zhaohui Jiang, Xin Zhou, Yin Li, Ping Liu, Yihong Chen, Jun Tan, Changjing Cai, Ying Han, Shan Zeng, and et al. 2023. "A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma" Journal of Clinical Medicine 12, no. 4: 1286. https://doi.org/10.3390/jcm12041286
APA StyleLiu, Y., Jiang, Z., Zhou, X., Li, Y., Liu, P., Chen, Y., Tan, J., Cai, C., Han, Y., Zeng, S., Shen, H., & Feng, Z. (2023). A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma. Journal of Clinical Medicine, 12(4), 1286. https://doi.org/10.3390/jcm12041286